Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
Kedhi E, Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WA, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van' T Hof AW, Lee SW, Roolvink V, Ligtenberg E, Postma S, Kolkman EJ, Brouwer MA, Dudek D, De Luca G. Kedhi E, et al. Among authors: dilling boer d. Atherosclerosis. 2021 Mar;321:39-44. doi: 10.1016/j.atherosclerosis.2021.02.006. Epub 2021 Feb 16. Atherosclerosis. 2021. PMID: 33639478 Clinical Trial.
How many times can a heart be broken?
Mulleners T, Dilling-Boer D, Benit E. Mulleners T, et al. Acta Cardiol. 2009 Jun;64(3):435-8. doi: 10.2143/AC.64.3.2038037. Acta Cardiol. 2009. PMID: 19593962
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial.
Verdoia M, Suryapranata H, Damen S, Camaro C, Benit E, Barbieri L, Rasoul S, Liew HB, Polad J, Ahmad WAW, Zambahari R, Lalmand J, van der Schaaf RJ, Koh TH, Timmermans P Sr, Dilling-Boer D, Veenstra LF, Van't Hof AWJ, Lee SWL, Roolvink V, Ligtenberg E, Postma S, Kolkman EJJ, Brouwer MA, Kedhi E, De Luca G. Verdoia M, et al. Among authors: dilling boer d. J Thromb Thrombolysis. 2021 Oct;52(3):797-807. doi: 10.1007/s11239-021-02439-x. Epub 2021 Apr 13. J Thromb Thrombolysis. 2021. PMID: 33847862 Clinical Trial.
Effect of reinforced, targeted in-person education using the Jessa Atrial fibrillation Knowledge Questionnaire in patients with atrial fibrillation: A randomized controlled trial.
Desteghe L, Engelhard L, Vijgen J, Koopman P, Dilling-Boer D, Schurmans J, Delesie M, Dendale P, Heidbuchel H. Desteghe L, et al. Eur J Cardiovasc Nurs. 2019 Mar;18(3):194-203. doi: 10.1177/1474515118804353. Epub 2018 Oct 17. Eur J Cardiovasc Nurs. 2019. PMID: 30328701 Clinical Trial.
Ablation of focally induced atrial fibrillation: selective or extensive?
Dilling-Boer D, Van Der Merwe N, Adams J, Foulon S, Goethals H, Willems R, Ector H, Heidbuchel H. Dilling-Boer D, et al. J Cardiovasc Electrophysiol. 2004 Feb;15(2):200-5. doi: 10.1046/j.1540-8167.2004.03385.x. J Cardiovasc Electrophysiol. 2004. PMID: 15028051
27 results